Search Result "Abiraterone Acetate"
A Rapid, Direct and Validated HPLC- Fluorescence Method for the Quantification of Abiraterone and Abiraterone Acetate in Urine and Serum Samples from Patients with Castration- Resistant Prostate Cancer
Journal: Current Pharmaceutical Analysis
Volume: 14 Issue: 3 Year: 2018 Page: 233-238
Author(s): Juana Rodriguez,Gregorio Castaneda,Isabel Lizcano,Jose C. Villa
Implementation of Quality by Design Approach for Optimization ofRP-HPLC Method for Quantification of Abiraterone Acetate in SolidDispersion in Forced Degradation Studies
Journal: Current Chromatography
Volume: 9 Issue: 1 Year: 2022 Page: 78-94
Author(s): Mahipal Reddy Donthi,Ranendra Narayan Saha,Sunil Kumar Dubey
Ascending Flaccid Paralysis Secondary to Hypokalemia in A Cancer Patientusing Abiraterone - A Case Report
Journal: Current Drug Safety
Volume: 18 Issue: 1 Year: 2023 Page: 107-111
Author(s): Daniella Cristina Brites de Almeida,Aline Luiza Costa,Barbara Lacerda de Oliveira Faria,Frederico Bruzzi de Carvalho,Marco Tulio Gualberto Cintra
Abiraterone Acetate, in Combination with Apigenin, Attenuates the Survival ofHuman Castration-Sensitive Prostate Cancer Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 18 Year: 2022 Page: 3148-3156
Author(s): Ugur Simal Atabey
Treatment of Metastatic, Castration-resistant, Docetaxel-resistant Prostate Cancer: A Systematic Review of Literature With a Network Meta-analysis of Randomized Clinical Trials
Journal: Reviews on Recent Clinical Trials
Volume: 13 Issue: 3 Year: 2018 Page: 226-237
Author(s): Davide Tassinari,Chiara Cherubini,Britt Roudnas,Emiliano Tamburini,Fabrizio Drudi,Emanuela Bianchi,Manuela Fantini,Francesco Montanari,Sergio Sartori
Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2011 Page: 296-306
Author(s): Jawaher Ansari, Syed A Hussain, Abdulla Alhasso, Rana Mahmood, Asif Ansari, John Glaholm
Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer
Journal: Current Drug Targets
Volume: 14 Issue: 4 Year: 2013 Page: 408-419
Author(s): Ai Chiin Lim, Gerhardt Attard
AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate Cancer
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 9 Year: 2018 Page: 869-876
Author(s): Samanta Salvi,Vincenza Conteduca,Cristian Lolli,Sara Testoni,Valentina Casadio,Andrea Zaccheroni,Lorena Rossi,Salvatore Luca Burgio,Cecilia Menna,Giuseppe Schepisi,Ugo De Giorgi
Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 4 Year: 2013 Page: 444-459
Author(s): Masaki Shiota, Akira Yokomizo, Naohiro Fujimoto, Hidetoshi Kuruma, Seiji Naito
Recent Development and Future Prospects of Molecular TargetedTherapy in Prostate Cancer
Journal: Current Molecular Pharmacology
Volume: 15 Issue: 1 Year: 2022 Page: 159-169
Author(s): Jinku Zhang,Jirui Sun,Sahar Bakht,Waseem Hassan